Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 May;84(2):185–189. doi: 10.1111/j.1365-2249.1991.tb08146.x

Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.

M Opravil 1, W Fierz 1, L Matter 1, J Blaser 1, R Lüthy 1
PMCID: PMC1535403  PMID: 2025948

Abstract

Ten patients with symptomatic HIV infection (six with ARC, four with AIDS) received tetanus and 23-valent pneumococcal vaccination. Anti-tetanus IgG and IgM, and anti-pneumococcal IgG against all 23 capsular types of the vaccine were measured on days 0, 11, 17, 30, and 90. Anti-pneumococcal IgG were simultaneously determined in two plasma pools of 100 healthy unimmunized blood donors and of 112 healthy adults who had previously received a 14-valent pneumococcal vaccination. Peak IgG responses to both vaccines were observed on day 17; thereafter, the antibody levels gradually fell again. Anti-tetanus IgG rose from 0.6 U/ml (geometric mean) to 2.0 U/ml on day 17. Anti-tetanus IgM remained unchanged. Anti-pneumococcal IgG increased only by 1.14-fold compared with pre-vaccination levels (geometric mean of IgG rises against all 23 polysaccharides in 10 patients), and exceeded the upper 95% limit of unvaccinated blood donors in only 30 out of 230 specimens. Pre-vaccination levels for pneumococcal type-specific IgG were significantly higher in HIV-infected patients compared with the pool of unimmunized healthy controls, possibly indicating a higher rate of previous pneumococcal infections in HIV-seropositive subjects. However, post-pneumococcal vaccination levels were significantly lower in HIV-infected patients than in the pool of healthy controls. The increase in anti-tetanus IgG significantly correlated with the level of CD4 lymphocytes and with in vitro lymphocyte proliferation by pokeweed mitogen (5 micrograms/ml) and phytohaemagglutinin (2.5 micrograms/ml), confirming a particularly low vaccination response in patients who were severely immunocompromised.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballet J. J., Sulcebe G., Couderc L. J., Danon F., Rabian C., Lathrop M., Clauvel J. P., Seligmann M. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol. 1987 Jun;68(3):479–487. [PMC free article] [PubMed] [Google Scholar]
  2. Huang K. L., Ruben F. L., Rinaldo C. R., Jr, Kingsley L., Lyter D. W., Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA. 1987 Apr 17;257(15):2047–2050. [PubMed] [Google Scholar]
  3. Janoff E. N., Douglas J. M., Jr, Gabriel M., Blaser M. J., Davidson A. J., Cohn D. L., Judson F. N. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis. 1988 Nov;158(5):983–990. doi: 10.1093/infdis/158.5.983. [DOI] [PubMed] [Google Scholar]
  4. Klein R. S., Selwyn P. A., Maude D., Pollard C., Freeman K., Schiffman G. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis. 1989 Nov;160(5):826–831. doi: 10.1093/infdis/160.5.826. [DOI] [PubMed] [Google Scholar]
  5. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  6. Matter L., Wilhelm J. A., Angehrn W., Skvaril F., Schopfer K. Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. N Engl J Med. 1985 Apr 18;312(16):1039–1042. doi: 10.1056/NEJM198504183121607. [DOI] [PubMed] [Google Scholar]
  7. Mufson M. A., Krause H. E., Schiffman G., Hughey D. F. Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci. 1987 May;293(5):279–284. doi: 10.1097/00000441-198705000-00001. [DOI] [PubMed] [Google Scholar]
  8. Mufson M. A., Krause H. E., Schiffman G. Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine. Proc Soc Exp Biol Med. 1983 Jun;173(2):270–275. doi: 10.3181/00379727-173-41643. [DOI] [PubMed] [Google Scholar]
  9. Musher D. M., Chapman A. J., Goree A., Jonsson S., Briles D., Baughn R. E. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986 Aug;154(2):245–256. doi: 10.1093/infdis/154.2.245. [DOI] [PubMed] [Google Scholar]
  10. SCHEIBEL I. The uses and results of active tetanus immunization. Bull World Health Organ. 1955;13(3):381–394. [PMC free article] [PubMed] [Google Scholar]
  11. Siber G. R., Ambrosino D. M., McIver J., Ervin T. J., Schiffman G., Sallan S., Grady G. F. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun. 1984 Jul;45(1):248–254. doi: 10.1128/iai.45.1.248-254.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Simberkoff M. S., El Sadr W., Schiffman G., Rahal J. J., Jr Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis. 1984 Dec;130(6):1174–1176. doi: 10.1164/arrd.1984.130.6.1174. [DOI] [PubMed] [Google Scholar]
  13. Stiffler-Rosenberg G., Fey H. Messung von Tetanus-Antitoxin mit dem Enzyme-linked immunosorbent assay (ELISA). Schweiz Med Wochenschr. 1977 Aug 6;107(31):1101–1104. [PubMed] [Google Scholar]
  14. Teeuwsen V. J., Logtenberg T., Siebelink K. H., Lange J. M., Goudsmit J., Uytdehaag F. G., Osterhaus A. D. Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation. J Immunol. 1987 Nov 1;139(9):2929–2935. [PubMed] [Google Scholar]
  15. Wüst J., Kayser F. H., Morenzoni G. Antimikrobielle Resistenz und Serotypen von Streptococcus pneumoniae in Zürich (1984/1985). Schweiz Med Wochenschr. 1987 Jun 6;117(23):868–873. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES